Detalhe da pesquisa
1.
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 389(21): 1961-1971, 2023 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870920
2.
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
N Engl J Med
; 381(1): 13-24, 2019 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31150574
3.
Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study.
Int J Urol
; 28(3): 280-287, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33295007
4.
Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.
Lancet Oncol
; 20(11): 1518-1530, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578173
5.
A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy.
J Clin Oncol
; 34(11): 1197-207, 2016 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26858335